Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 104
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Psychedelic Bulletin #135: A Misguided MDMA Price-Fixing Effort; Psilocybin Study’s Lukewarm...
Psychedelics Weekly – Roland Griffiths Faces the End, The NBA Lifts...
Clearmind Medicine Closes US$3.5 Million Public Offering
Expanding Your Horizons: The Ultimate Guide to Attending a Psychedelic Conference
Psychedelic Research Bulletin: March 2023
Small Pharma Announces Positive Six-month Data from Phase IIa Trial of...
PT403 – Understanding the Brain: Psychedelic Neuroscience Demystified
Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1...
First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics...
Load more
